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Monocyte inﬁltrationDuring the pathogenesis of atherosclerosis, adhesion of monocytes to vascular endothelium and subsequent
migration across the endothelium has been recognized as a key process in the chronic inﬂammatory response in
atherosclerosis. As type 2 diabetes is closely associated with the pathogenesis of atherosclerosis, we investigated
whether monocyte adhesion and migration were affected by insulin. We found that insulin activated Akt and in-
duced subsequentmigration in THP-1. However, glucose and insulin-like growth factor-1, which is a growth factor
that is structurally similar to insulin, were not effective. Insulin-dependent migration of THP-1 was blocked by in-
hibition of PI3K or Akt and by silencing of Akt1. Insulin-dependent migration of bone marrow-derivedmonocytic
cells (BDMCs)was attenuated by inhibition of PI3K andAkt. In addition, BDMCs fromAkt1−/−mice showeddefects
in insulin-dependent migration. Stimulation of THP-1 with insulin caused adhesion with human vein endothelial
cells (HUVECs) that was blocked by silencing of Akt1. However, stimulation of HUVECs did not cause adhesion
with THP-1. Moreover, BDMCs from Akt1−/−mice showed defects in insulin-dependent adhesionwith HUVECs. In-
sulin induced surface expression of Mac-1, and neutralization of Mac-1 blocked insulin-induced adhesion of THP-1
aswell as BDMCs. Surface expressionofMac-1was blocked in THP-1with silencedAkt1, and in BDMCs isolated from
mice lacking Akt1. Finally, trans-endothelial migration of THP-1 and BDMCswas blocked byMac-1-neutralizing an-
tibody, in THP-1 with silenced Akt1 and in BDMCs from Akt1−/−mice. These results suggest that insulin stimulates
monocyte trans-endothelial migration through Akt-dependent surface expression of Mac-1, which may be part of
the atherogenesis in type 2 diabetes.
© 2014 Elsevier B.V. All rights reserved.1. Introduction
Atherosclerosis is the most important leading cause of sudden
death in the world. Atherosclerosis is a condition in which an arterial
wall thickens as result of accumulation of lipids such as cholesterol
[1]. Lipid accumulation is caused by chronic inﬂammation, which is
mediated by migration of monocytes across the arterial walls, and
accumulating ox-LDLs harboring cholesterol and triacylglycerol to
macrophages. Therefore, understanding the mechanism of monocyte
trans-endothelialmigration is important for elucidating the pathogenesis
of atherosclerosis.
Glucose levels are commonly elevated in both type 1 and type 2
diabetes. Chronic hyperglycemia seems to be a contributing factor for
atherosclerosis, since glycemic control delays the onset of vasculargeneration, and Department of
icine, Bumeo-ri, Mulgeum-eup,complications [2]. In addition, high levels of glucose affect many types
of physiological responses involved in the pathogenesis of atherosclero-
sis [3–5]. Unlike in type 1 diabetes, insulin levels in patients with type 2
diabetes are signiﬁcantly increased since insulin resistance in metabolic
tissues fails to reduce blood glucose levels. Insulin resistance, which is
a typical characteristic in type 2 diabetes, is deﬁned as a decreased
response of theperipheral tissues to insulin action. Recently, atherosclerosis
was reported to be the cause of morbidity for 70% of patients with type 2
diabetes [6]. In addition, several reports indicate that insulin action is closely
associated with neointima formation and lipid accumulation in atheroscle-
rotic lesions [7,8]. Clinically, insulin treatment in patients with acute
myocardial infarction ameliorates their survival [9]. Thus, hyperinsulinemia
in addition to hyperglycemia seems to affect the progression of atheroscle-
rosis. However, the underlying mechanism by which insulin regulates the
progression of atherosclerosis is poorly understood.
Monocyte inﬁltration is a critical step for the initiation of chronic
inﬂammation and causes atherogenesis [1]. Monocyte-endothelial
cell interactions play a crucial role in the initiation of atherogenesis.
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sion of surface molecules that mediate intercellular adhesion on
both cell types [10]. ICAM-1 (CD54), ICAM-2, E-selectin (ELAM-1),
P-selectin (GMP-140, CD62), and VCAM-1 are expressed in endothelial
cells that mediate the interaction with monocytes [11]. Monocytes
express L-selectin and the integrin subfamily. L-selectin on the mono-
cytes interacts with E-selectin and P-selectin on endothelial cells after
the onset of the inﬂammatory response [12]. The integrin family of
heterodimeric molecules consists of an α subunit that is covalently
linked to a β subunit. VLA-4 (α4β1, CD49d/CD29), which is expressed
on monocytes, contributes to the adhesion with VCAM-1 on activated
endothelial cells [13]. Monocytes also express β2 subunit-containing
integrins such as LFA-1 (αLβ2, CD11a/CD18), Mac-1 (αMβ2, CD11b/
CD18), and CR4 (αXβ2, CD11c/CD18) tomediate adhesionwith cell sur-
face receptors on endothelial cells [14–16]. The importance of adhesion
molecules in leukocytes has been reported previously. For example,
insufﬁcient expression of functional β2-integrin molecules is observed
in LAD syndrome and patients with LAD suffer from life-threatening
infections due to failure of leukocyte extravasation [17].
Expression of adhesive molecules in endothelial cells seems to be a
major mechanism by which extracellular stimuli enhance monocyte
adhesion to endothelial cells. For example, many inﬂammatory cyto-
kines trigger expression of adhesive molecules in endothelial cells,
thereby enhancing leukocyte adhesion [18]. In addition to inﬂammatory
cytokines, hyperglycemia is reported to contribute to the expression of
adhesive molecules in endothelial cells to induce monocyte adhesion.
For instance, prolonged exposure to high glucose induces the expres-
sion of ICAM-1 and VCAM-1 in endothelial cells, thereby enhancing
their adhesion to monocytes [5,19]. Insulin has also been reported
to stimulate endothelial cells to express VCAM-1 [20]. However, the
effect of insulin is debated. For instance, insulin inhibits the expres-
sion of ICAM-1 through stimulation of nitric oxide and thereby
suppresses monocyte adhesion to endothelial cells [21]. Although
leukocyte activation is also important for monocyte trans-endothelial
migration, the effect of insulin on the activation of monocytes is still
not clear.
In the present study, we investigated the role of insulin on the
activation of monocytes. In particular, insulin-dependent monocyte
cell migration, adhesion, and trans-endothelial migration have been
examined in THP-1 cells and bone marrow-derived mononuclear cells
from animal models. Moreover, we have examined the role of Mac-1
translocation upon insulin stimulation in the activation of monocytes.
2. Material and methods
2.1. Reagents
All culture media were from Hyclone Laboratories Inc. (Logan, UT,
USA). Rabbit polyclonal antibodies against Akt1 and Anti-GAPDH were
obtained from Millipore Bioscience (Temecula, CA, USA). Anti-pan-
Akt, anti-phospho-Akt (Ser473), anti-phospho-ERK and anti-ERK anti-
bodies were purchased from Cell Signaling Technology (Boston, MA,
USA). Both anti-Mac-1 and FITC-conjugated anti-Mac-1 antibodies
were obtained fromMiltenyi Biotec Inc. (Auburn, CA, USA). PI3K inhib-
itor (LY294002) and Akt inhibitor (SH-5) were from Calbiochem
(Darmstadt, Germany). ChemoTx membrane (8-μm pore size) was
obtained from Neuro Probe Inc. (Gaithersburg, MD, USA). IRDye700-
or IRDye800-conjugated rabbit or mouse secondary antibody was ob-
tained from Li-COR Bioscience (Lincoln, NE, USA). Insulin and all other
high quality reagents were purchased from Sigma-Aldrich (St Louis,
MO, USA) unless otherwise indicated.
2.2. Animals
Mice lacking Akt1 (Akt1−/−, C57B6.129P2-Akt1tm1Mbb/J) were
purchased from The Jackson Laboratory (Bar Harbor, Maine, USA).Mice were housed under SPF conditions. All animal procedures were
performed in accordance with our institutional guidelines for animal
research, and were approved by our institutional animal care and
use committee (PNU-2009-0008). The investigation conforms to the
Guide for the Care and Use of Laboratory Animals published by the US
National Institutes of Health (NIH Publication, 8th edition, 2011).2.3. Cell isolation and culture
To isolate BDMCs, mice were euthanized via peritoneal injection of
sodium pentobarbital (60 mg/kg). Under aseptic conditions, the skin
of Akt+/+ and Akt1−/− mice was peeled from the top of each hind leg
and down over the foot. Feet with skin were cut off and hind legs
were placed on dishes containing sterile PBS. Muscle tissues surround-
ing the femur and tibia were removed with scissors, and the bones
were placed in 5 ml of 70% ethanol for 1 min. The bones were washed
twice with PBS and transferred to 60-mm petri dishes containing 10
ml of serum-freemedium. Both ends of the boneswere cutwith scissors
to expose the lumen, and the bones were ﬂushed out using a 1-ml
syringe containing serum-free medium. The marrow suspension was
vigorously pipetted to disrupt any clusters present in the suspension.
Red blood cells were lysed with lysing buffer (Sigma-Aldrich Corp., St
Louis, MO, USA) and the cell suspension was separated by Ficoll-
Hypaque (Sigma-Aldrich Corp., St Louis, MO, USA). After centrifugation
at 2400 rpm for 30 min, the cell pellets were resuspended in RPMI
medium containing 10% FBS. THP-1 human monocytic leukemia cells
were maintained in suspension in RPMI containing 10% (v/v) fetal
bovine serum and penicillin/streptomycin, and incubated at 37 °C in
5% CO2. HUVECs were isolated from fresh newborn umbilical vein
according to a conventional protocol [22]. Cells were grown on type 1
collagen-coated dishes and cultured in EGM2-MV Bullet kits (Lonza,
Walkersville,MD, USA) containing 1% antibiotics. Cells between passage
1 and 3 were used in this study.2.4. Cell migration assay
To test the effect of both insulin and glucose, we examined cell mi-
gration in glucose-free KRP buffer (136 mM NaCl, 4.7 mM KCl, 0.9 mM
MgSO4, 0.9 mM CaCl2, 10 mM NaH2PO4, pH 7.4). Both THP-1 and
BDMCs were starved with KRP buffer for 4 h before plating on the
ChemoTx membrane. For the migration assay, the bottom side of
ChemoTx membrane was coated with Type I collagen for 30 min, and
a total of 1 × 105 serum-starved cells in 50 μL volume were placed
on the top side of ChemoTx membrane. Migration was induced by
submerging the ChemoTx membrane in KRP buffer in the presence or
absence of insulin for 3 h. The ChemoTx membrane was ﬁxed with 4%
paraformaldehyde and non-migrated cells on the top side of the mem-
branewere removed bywipingwith a cotton swab. Themembranewas
stained with DAPI and migrated cells were counted with the ﬂuores-
cence microscope at ×10 magniﬁcation (Axiovert200, Carl Zeiss, Jena,
Germany).2.5. Adhesion assay
For adhesion assays, HUVECs were grown to 100% conﬂuence in a
48-well dishes, and 7 × 105 calcein acetoxymethyl ester (calcein AM,
Invitrogen, Carlsbad, CA, USA)-labeled THP-1 monocytes and BDMCs
were added to each well. Cells were incubated in the presence or
absence of insulin (100 nM) for the indicated times (0–120 min). Each
well was rinsed three times with PBS containing 1% BSA to remove
unbound cells. Plates were ﬁxed with 4% paraformaldehyde, and
calcein-labeled THP-1 cells or BDMCs bound to HUVECs were counted
under the ﬂuorescence microscope at × 10 magniﬁcation.
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Trans-endothelial migration assay was performed essentially as de-
scribedpreviously [23]. In brief, trans-well inserts (CorningCostar Corp.,
Cambridge, MA, USA) were coated with 50 μg of matrigel (BD Biosci-
ence, San Jose, CA, USA). HUVECs were seeded and grown to conﬂuence
on inserts. THP-1 and BDMCs were serum-starved for 4 h and labeled
with calcein AM. Cells were overlaid on top of the HUVECs and trans-
endothelial migration was induced by placing the inserts on serum-
free medium in the absence or presence of insulin for 3 h. Cells on the
top side of themembranewere removed by gentlywipingwith a cotton
swab. Transmigrated cells were counted under the ﬂuorescence micro-
scope at × 10 magniﬁcation.
2.7. Lentiviral gene silencing
Akt1 was silenced as described previously [23]. Brieﬂy, HEK293FT
packaging cells were grown to ~70% conﬂuency in 100-mm cell culture
dishes. Cells were triple transfected with 5 μg of Δ8.9, 5 μg of pVSV/G
and 20 μg of pLKO.1 lentiviral vector containing shAkt1 or shAkt2 by
the calcium phosphate method. Mediumwas replaced with freshmedi-
um 8 h post-transfection. Lentiviral supernatants were harvested 24 h
post-transfection and passed through a 0.45-μm ﬁlter. Cell-free viral
culture supernatants were used to infect THP-1 monocytes in the pres-
ence of 8 μg/ml of polybrene. An additional round of infection was per-
formed at 48 h post-transfection. Infection was validated by selection
with 10 μg/ml of puromycin for 2 days.
2.8. Quantiﬁcation of Mac-1 translocation
THP-1 monocytes were serum-starved for 4 h, and then stimulated
with insulin (100 nM) for 30 min. To examine the surface expression
of Mac-1, cells were rinsed with 1% BSA in PBS, incubated with anti-
Mac-1 antibody (Miltenyi Biotec Inc., Auburn, CA, USA) for 20 min,
and ﬁxed in 4% paraformaldehyde for 15 min. Images were obtained
with a confocal microscope at ×40 magniﬁcation (OLYMPUS FV-1000,
Tokyo, Japan). Pixel intensity in a ﬁeld was measured by MetaMorph
software (Molecular Devices, Sunnyvale, CA, USA) and surface translo-
cation of Mac-1 was expressed by the ratio of pixel intensity over the
number of cells in a ﬁeld.
2.9. Western blotting
Cells were lysed in 20mMTris–HCl, pH 7.4, 1mMEGTA/EDTA, 1% Tri-
ton X-100, 1 mM Na3VO4, 10% glycerol, 1 μg/ml leupeptin and 1 μg/ml
aprotinin. After centrifugation at 12,000 rpm, thirty micrograms of
total protein were loaded into 10% polyacrylamide gels and transferred
onto nitrocellulose membranes. Membranes were incubated with the
indicated primary antibodies and IRDye-conjugated secondary antibod-
ies, and protein bands were visualized with infrared image analyzer
(Li-COR Bioscience).
2.10. Statistical analysis
Data are expressed as means ± S.D. of three independent experi-
ments (n= 3 for each experiment). The statistical differences between
treated and non-treated groupswere analyzed by an unpaired Student's
t-test to assess differences. P-values less than 0.05 were considered
signiﬁcant and indicated by *.
3. Results
3.1. Insulin stimulates migration of THP-1 monocytes
To verify the effect of type 2 diabetic conditions on monocyte cell
activation,we examined the effect of glucose or insulin on themigrationof THP-1monocytes. Insulin (100 nM) strongly promoted themigration
of THP-1 monocytes in a time dependent manner (Fig. 1A). Migration
reached a maximum within 60 min after stimulation. In addition, insu-
lin initiated the migration of THP-1 monocytes at concentrations be-
tween 1 nM and 1 μM (Fig. 1B). However, high-concentration glucose
(25 mM) did not affect the migration of THP-1 monocytes. Moreover,
IGF-1, a growth factor that is structurally similar to insulin, did not
induce the migration of THP-1 monocytes (Fig. 1A). Furthermore, Akt
was activated by insulin in a time-dependent manner but not by IGF-1
and glucose (Fig. 1C and D). In addition, activation of Akt was initiated
with 1 nM insulin (Fig. 1E). These results suggest that insulin stimulates
the migration of THP-1 monocytes.
3.2. Akt1 is required for insulin-induced migration of THP-1 monocytes
To deﬁne the molecular mechanism underlying insulin-induced
migration of THP-1 monocytes, pharmacological inhibitors were used
to speciﬁcally interfere with insulin signaling pathways. Activation of
Akt was signiﬁcantly reduced in THP-1 cells pretreated with either
PI3K (LY, 10 μM) or Akt inhibitor (SH-5, 50 μM) (Fig. 2A). Inhibition of
PI3K and Akt signiﬁcantly inhibited insulin-induced migration of THP-
1 monocytes (Fig. 2B). However, insulin did not signiﬁcantly activate
p38 MAPK or ERK1/2. In addition, inhibition of p38 MAPK or ERK did
not affect insulin-induced migration of THP-1 cells. To further conﬁrm
the essential role of Akt isoform in insulin-induced migration of THP-1
monocytes, either Akt1 or Akt2 was silenced in THP-1 monocytes
(Fig. 3C). Silencing of Akt1 signiﬁcantly abrogated insulin-induced
migration of THP-1 monocytes, whereas silencing Akt2 did not affect
(Fig. 3D). These results suggest that Akt1 plays an essential role in
insulin-induced migration of THP-1 monocytes.
3.3. BDMCs lacking Akt1 show defects in insulin-induced migration
To further verify the role of Akt1 primary mononuclear cells, we
isolated mononuclear cells from bone marrow (BDMCs). Insulin signif-
icantly promoted the migration of BDMCs in a time- (Fig. 3A) and
dose-dependent (Supplemental Fig. S1C) manner. Migration of BDMCs
reached a maximum within 60 min after stimulation with insulin.
Insulin-induced BDMCsmigrationwas signiﬁcantly blocked by pharma-
cological inhibition of PI3K and Akt (Fig. 3B). To further conﬁrm the role
of Akt in mononuclear cell migration, we isolated mononuclear cells
from mice lacking Akt1 (Fig. 3C). Insulin-induced migration was signif-
icantly impaired in BDMCs isolated from Akt−/− mice compared with
Akt+/+mice (Fig. 3D). These results suggest that Akt1 is necessary for
insulin-induced migration of mononuclear cells.
3.4. Insulin stimulates monocytes to adhere on endothelial cells through
Akt1 activation
Since adhesion of monocytes to endothelial cells is also important
for monocyte inﬁltration during various physiological responses, we
examined the effect of insulin on the adhesion of THP-1 monocytes to
endothelial cells. Insulin stimulated adhesion of THP-1 monocytes to
HUVECs in dose-dependent manner (Supplemental Fig. S1A). In addi-
tion, adhesion of THP-1 monocytes to HUVECs was signiﬁcantly en-
hanced by insulin in time-dependent manner (Fig. 4A). Since insulin
can affect both THP-1 monocytes and HUVECs, we examined whether
insulin stimulates adhesion through activation of THP-1 monocytes or
HUVECs or both. To determine the target cell of insulin, both THP-1
monocytes and HUVECs were separately pretreated with insulin for
30 min. Pretreatment of both cell types with insulin resulted in en-
hanced adhesion (Fig. 4B). Pretreatment of THP-1 monocytes but not
HUVECs also enhanced adhesion (Fig. 4C). However, pretreatment of
HUVECs with insulin did not affect adhesion of THP-1 monocytes
(Fig. 4D).We next examined the effect of Akt on adhesion of monocytes
to endothelial cells. Insulin-induced adhesion of THP-1 monocytes was
Fig. 1. Insulin stimulates THP-1 monocyte migration. (A) Migration of THP-1 monocytes were assessed after stimulation with high glucose (25 mM), insulin (100 nM), and IGF-1
(50 ng/ml) at the indicated times. (B) Migration of THP-1 monocytes was assessed at the indicated doses of insulin. Data are means ± S.D. of three independent experiments (n= 3).
Asterisks indicate statistical signiﬁcance (P b 0.05). (C) THP-1 monocytes were stimulated with insulin (100 nM), high glucose (25 mM), or IGF-1 (50 ng/ml), and activation of Akt
was veriﬁed by Western blot analysis. Signaling molecules were examined after stimulation of THP-1 monocytes with insulin at the indicated times (D) and doses (E).
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(Fig. 4E and F). However, inhibition of MAPK signaling pathways did
not affect insulin-induced adhesion of THP-1 cells (Supplemental
Fig. S6A). Silencing of Akt1 in THP-1 monocytes abrogated insulin-
induced adhesion whereas silencing of Akt2 did not affect (Fig. 4G and
Supplemental Fig. S6B). Insulin stimulated BMDCs adhesion to HUVECs
in a dose-dependent manner (Supplemental Fig. S1D). In addition,
insulin-induced adhesion was impaired in BDMCs isolated from mice
lacking Akt1 (Fig. 4H). These results suggest that insulin activates
monocytes and induces adhesion to endothelial cells in an Akt1-
dependent manner.3.5. Surface expression of Mac-1 is required for insulin-induced adhesion of
THP-1 monocytes
Since insulin stimulates THP-1 monocytes to adhere to endothelial
cells, we examined the effect of insulin on adhesion molecules in THP-
1 monocytes. Mac-1 is expressed and stored in intracellular vesicles
and translocated to the plasmamembrane in response to monocyte ac-
tivation, thereby regulating adhesion of monocytes to endothelial cells
[24]. Stimulation of THP-1 monocytes with insulin induced the translo-
cation of Mac-1 to the plasma membrane (Fig. 5A, B, and Supplemental
Fig. S2A). Insulin-stimulated adhesion of THP-1 monocytes with
HUVECs was completely abolished by Mac-1-neutralizing antibody
(Fig. 5C). In addition, neutralization of Mac-1 abrogated insulin-
induced adhesion of mononuclear cells isolated from mice (Fig. 5D).
Likewise, CR4-neutralizing antibody completely blocked insulin-
induced adhesion of THP-1 cells (Supplemental Fig. S2B). These results
suggest that surface expression of Mac-1 and/or CR-4 is required for
insulin-induced adhesion of monocytes to endothelial cells.3.6. PI3K/Akt1 signaling pathway is necessary for surface expression of
Mac-1
Since Akt1 is required for the adhesion of monocytes (Fig. 4) and
surface expression ofMac-1 is also important for the adhesion of mono-
cytes (Fig. 5), we examined the involvement of the PI3K/Akt signaling
pathway in the surface expression of Mac-1. Surface expression of
Mac-1 was signiﬁcantly reduced by pharmacological inhibition of PI3K
(Fig. 6A). Insulin-induced surface expression of Mac-1 in THP-1 mono-
cytes was abrogated by silencing of Akt1 (Fig. 6B). In addition, insulin-
induced surface expression of Mac-1 was impaired in BDMCs isolated
from mice lacking Akt1 (Fig. 6C). These results suggest that Akt1 is
required for insulin-induced surface expression of Mac-1.3.7. Akt1-dependent surface expression of Mac-1 regulates trans-
endothelial migration of monocytes
Migration of monocytes across endothelial cells is an important
physiological step for the pathogenesis of atherosclerosis. Trans-
endothelial migration of THP-1 cells was strongly promoted by insulin
in a dose-dependent manner (Supplemental Fig. 1B). To verify the role
of surface expression of Mac-1 in trans-endothelial migration of mono-
cytes, we examined the effect of Mac-1-neutralizing antibody on the
trans-endothelial migration of monocytes. Trans-endothelial migration
of both THP-1monocytes and BDMCswas signiﬁcantly blocked byMac-
1-neutralizing antibody (Fig. 7A and B). Silencing of Akt1 in THP-1
monocytes signiﬁcantly reduced insulin-induced trans-endothelial
migration (Fig. 7C). In addition, mononuclear cells isolated from mice
lacking Akt1−/− showed defects in insulin-induced trans-endothelial
migration (Fig. 7D). These results suggest that Akt1 is required for
Fig. 2. Akt1 is required for insulin-induced migration of THP-1 monocytes. After THP-1 monocytes were pretreated with the indicated inhibitors (LY, LY294002; SH-5, Akt inhibitor; PD,
PD98059; SB, SB203580), activation of signaling molecules (A) and migration (B) was veriﬁed. Either Akt1 or Akt2 was silenced in THP-1 monocytes, and expression of each Akt isoform
(C) and migration (D) was determined. Data are means ± S.D. of three independent experiments (n= 3). Asterisks indicate statistical signiﬁcance (P b 0.05).
Fig. 3. Akt1 is necessary for insulin-inducedmigration of BDMCs. (A) BDMCswere isolated frommice and insulin-inducedmigrationwas assessed at the indicated times. (B) BDMCswere
pretreated with the indicated inhibitors and insulin-induced migration was measured. BMDCs were isolated from mice lacking Akt1, and expression of Akt1 (C) and insulin-induced
migration (D) were assessed. Data are means ± S.D. of three independent experiments. N= 3 for each group. Asterisks indicate statistical signiﬁcance (P b 0.05).
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Fig. 4. Akt1 regulates adhesion of THP-1 monocytes to endothelial cells. (A) THP-1 monocyte adhesion to HUVECs were measured in the presence or absence of insulin at the indicated
times. (B) Both THP-1 monocytes and HUVECs were primed with insulin for 30 min and then washed two times with serum-free medium. Insulin-primed THP-1 cells were placed on
insulin-primed HUVECs and adhesion was measured at the indicated times. The rest of the experiments were performed after priming either THP-1 monocytes (C) or HUVECs
(D). THP-1 monocytes were pretreatedwith the indicated inhibitors, and the Akt activation (E) and insulin-induced adhesion (F) were determined. (G) Insulin-induced THP-1monocyte
adhesion was measured after silencing Akt1. (H) Insulin-induced adhesion was assessed in BDMCs isolated from wild type mice or mice lacking Akt1. Data are means ± S.D. of three
independent experiments. N= 3 for each group. Asterisks indicate statistical signiﬁcance (P b 0.05).
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migration of monocytes.
4. Discussion
Hyperinsulinemia represents a defect in insulin action during meta-
bolic regulation. Elevation of insulin concentration is believed to be the
result of a compensatory response to insulin resistance [25]. Thus, the
pathological effect of hyperinsulinemia in type 2 diabetes has largely
been ignored. However, there are still some debates regarding insulin
action in insulin-resistant conditions, i.e., whether diabetic complica-
tions are affected by high insulin concentration or whether defects in
insulin action simply cause the progression of diabetic complications.Fig. 5. Blocking Mac-1 attenuates insulin-induced THP-1 monocyte and BMDCs adhesion. (A) T
were stained withMac-1 antibody for 10min in the absence of the permeabilization step. Imag
wasmeasured byMetaMorph software. Both THP-1monocytes (C) and BMDCs (D)were treate
measured. Data are means ± S.D. of three independent experiments (n= 3). Asterisks indicatIn the present study, we demonstrated that a high concentration of
insulin stimulated the activation of monocytes, thereby enhancing
monocyte trans-endothelial migration. In addition, we showed that
Akt1 relayed insulin signaling to surface expression of Mac-1, thereby
enhancing insulin-induced adhesion and migration of monocytes.
Patients with type 2 diabetes display a high risk for the development
of atherosclerosis [6]. In its deﬁnition, insulin resistance in type 2 diabe-
tes speculates malfunction of insulin receptor signaling in monocytes
that facilitates the progression of atherosclerosis. However, it is still de-
batable whether impaired insulin signaling exerts a positive or negative
effect on the progression of atherosclerosis. An example of a positive
effect on atherosclerosis was demonstrated by the systemic loss of
Akt1 in a rodent model. Blocking the insulin signaling pathway byHP-1 monocytes were serum-starved for 4 h and stimulated with insulin for 30 min. Cells
es were captured on confocal microscope at ×40magniﬁcation. (B) Fluorescence intensity
dwith insulin in the presence or absence ofMac-1 neutralizing antibody and adhesionwas
e statistical signiﬁcance (P b 0.05).
Fig. 6. Surface expression of Mac-1 is regulated by Akt1. (A) Surface expression of Mac-1 was assessed in the presence or absence of PI3K inhibitor and quantiﬁed by measuring
ﬂuorescence intensity with MetaMorph software. Surface expression of Mac-1 was measured in THP-1 monocytes with silenced Akt1 (B) and in BDMCs isolated from mice lacking
Akt1 (C). Data are means ± S.D. of three independent experiments. N= 3 for each group. Asterisks indicate statistical signiﬁcance (P b 0.05).
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eration of a bone marrow-speciﬁc Akt1 knockout by transplantation
method was not sufﬁcient to enhance lesion progression. This conﬂict
was further addressed using a tissue-speciﬁc knockout mice model of
insulin receptor [27]. In this report, myeloid-speciﬁc knockout of insulin
receptor impaired the progression of atherosclerosis. More importantly,
generation of macrophage-speciﬁc knockout model of IRS2 by adaptive
transfer dissipated high-fat diet-induced atherosclerosis, suggesting
that insulin signaling is important for atherogenesis. In addition, consid-
erable evidence supports the association between insulin levels and
progression of atherosclerosis in animal models. For instance, type 1
diabetic rabbits fed a high-cholesterol diet had lower prevalence of
atherosclerosis than non-diabetic animals, and developed atherosclero-
sis after treatmentwith insulin [28,29]. In another experiment, systemic
or local infusion of insulin signiﬁcantly facilitated atherogenic
plaque formation [30,31]. Clinically, several studies have shown that in-
sulin level is closely associated with atherosclerotic events [32–34].
Therefore, it seems reasonable that the insulin signaling pathway in
monocytes is required for the progression of atherosclerosis. Although
many studies have demonstrated impairment of insulin signaling
in the metabolic tissues of a diabetic murine model, the presence ofinsulin signaling in monocytes remains to be elucidated under
hyperinsulinemic conditions.
Migration of monocytes across endothelium is a key initiating pro-
cess of atherogenesis [35]. Trans-endothelial migration of a monocyte
is facilitated by activation of the monocyte itself, in addition to the
activation of endothelial cells through various growth factors, metabo-
lites, and inﬂammatory cytokines [1]. Therefore, the issues of trans-
endothelial migration of monocytes have rested on the expression of
adhesion molecules in both monocytes and endothelial cells. Indeed,
long-term exposure to high glucose or insulin induces endothelial
cells to express adhesionmolecules, thereby inducing adhesion of endo-
thelial cells to monocytes [5,19,36]. In addition, long-term exposure to
high glucose or insulin activates monocytes and enhances migration
and adhesion [37–39]. However, there seems to be a differential effect
of insulin and high glucose on monocytes and endothelial cells in re-
sponse to short-term exposure. Short-term exposure to high glucose
was not effective on monocyte migration (Fig. 1). On the other hand,
adhesion and migration of monocytes were signiﬁcantly enhanced in
response to short-term exposure to insulin (Figs. 1 and 4). It is also note-
worthy that insulin exclusively exerts its effect on monocytes rather
than endothelial cells (Fig. 4). Therefore, it is likely that insulin has
Fig. 7. Trans-endothelial migration is regulated by Akt1 andMac-1. Mac-1was blocked by neutralizing antibody in both THP-1 monocytes (A) and BDMCs (B), and insulin-induced trans-
endothelial migration was measured. Insulin-induced trans-endothelial migration was measured in THP-1 monocytes with silenced Akt1 (C) or BDMCs isolated from mice lacking Akt1
(D). Data are means ± S.D. of three independent experiments. N= 3 for each group. Asterisks indicate statistical signiﬁcance (P b 0.05).
1546 S.Y. Jin et al. / Biochimica et Biophysica Acta 1842 (2014) 1539–1548pro-atherogenic effect mediated by long-term gene expression and
short-term activation of THP-1 cells. In addition to this short-term effect
of insulin onmigration and adhesion, insulinmarkedly enhanced prolif-
eration as well as expression of CD36 which is important for the uptake
of oxidized LDL during foam cell formation (Supplemental Fig. S4A and
S4B). However, stimulation of THP-1 cells with insulin did not change
the expression level of anti-inﬂammatory and pro-inﬂammatory cyto-
kines, indicating that insulin-dependent chemokine expression in
THP-1 cells seems not to be involved in insulin-induced THP-1 cell mi-
gration and adhesion (Supplemental Fig. S4C). Therefore, it is reason-
able to suggest that insulin has adverse effect on atherosclerosis by
enhancingmonocyte inﬁltration, proliferation, and foam cell formation.
Since insulinmainly activatedmigration and adhesion ofmonocytes,
the counterpart of adhesive molecules in endothelial cells was investi-
gated in this study. Mac-1/CD18 is reported to contribute to the mono-
cyte adhesion to endothelial cells by binding vascular cell adhesion
molecules [40]. Surface expression of Mac-1 seems to be important for
acute responses of monocytes. For example, in the resting state, Mac-1
is expressed and stored in peroxisome-negative vesicular compart-
ments in the cytosol; it translocates to the plasma membrane upon
stimulation with various inﬂammatory cytokines [41,42]. More impor-
tantly, surface expression of Mac-1 seems to be important for the adhe-
sion of monocytes since loss of Mac-1 surface expression causes loss of
neutrophil adhesion [43]. Similarly, our results showed that insulin
promotes surface expression of Mac-1 and neutralization of Mac-1
completely blocks insulin-induced adhesion and trans-endothelialmigration of THP-1monocytes (Figs. 5 and 7). Persistent surface expres-
sion of Mac-1 is also observed in hyperinsulinemic type 2 diabetes [44].
Therefore, surface expression of Mac-1 seems to be important for the
acute response of monocytes upon insulin stimulation.
It has been reported that insulin facilitates monocyte migration
through ERK-dependent expression of MMP-9 [37]. In the present
study, we have demonstrated that the PI3K/Akt signaling pathway,
which is a major downstream signaling pathway of insulin action [45],
seems to play a key role in the activation ofmonocytes. Pharmacological
inhibition of PI3K signiﬁcantly blocked insulin-dependent migration,
adhesion, and surface expression of Mac-1 (Figs. 2, 3, 4, and 6). In addi-
tion, silencing or ablation of Akt1 dampened insulin-inducedmigration,
adhesion, surface expression of Mac-1, and trans-endothelial migration
(Figs. 2, 3, 4, 6, and 7). In animal model, loss of Akt1 signiﬁcantly atten-
uated monocyte inﬁltration into plaque lesion (Supplemental Fig. S3).
Thus, Akt1 might be a key regulator of insulin-induced inﬁltration of
monocytes. The mechanism by which Akt regulates translocation of
the Mac-1 containing vesicle is still unknown. In the mechanistic path-
way, regulation of Mac-1 surface expression is associated with actin
cytoskeletal rearrangement [46]. Likewise, Akt regulates cell migration
through control of actin cytoskeletal rearrangement [47]. In addition,
Akt is involved in the GLUT4 containing vesicle upon insulin stimulation
and thereby regulates glucose uptake in muscle and adipose tissues
[48,49]. Therefore, an analogous mechanism could be applied to Akt-
mediated translocation of Mac-1-containing vesicles to the plasma
membrane.
1547S.Y. Jin et al. / Biochimica et Biophysica Acta 1842 (2014) 1539–1548In conclusion, we found that insulin rapidly induces the migration,
adhesion, and trans-endothelial migration of monocytes. The PI3K/Akt
signaling pathway is involved in the insulin-dependent activation
of monocytes. Surface expression of Mac-1 plays a key role in the
insulin-dependent adhesion and trans-endothelial migration and it
requires PI3K/Akt signaling pathways. As trans-endothelial migration
is important for the initiation of atherosclerosis, insulin-dependent
surface expression of Mac-1 may play a key role in the progression of
atherosclerosis.
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